Join
Live feed
·
INSIDERFilingvia Quantisnow
Clarus Therapeutics Holdings Inc. logo

SEC Form 4: Amory John Kenneth was granted 3,844 shares

ByQuantisnow·Wall Street's wire, on your screen.
CRXT· Clarus Therapeutics Holdings Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRXT (Clarus Therapeutics Holdings Inc.) and more on Quantisnow.